Massive heart failure platform trial aims to find better treatments

NCT ID NCT07428135

Not yet recruiting Disease control Sponsor: University of Alberta Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times

Summary

This platform trial will enroll 1,000 adults with heart failure to test several different treatments at the same time. Participants are randomly assigned to either an experimental intervention or standard care. The main goal is to see if these treatments can prevent death or hospitalization due to heart problems.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Various interventions (drugs, devices, or procedures) tested within the platform; details depend on the specific domain.
What this could lead to: If successful, this platform could identify effective treatments to reduce death and hospitalizations for people with heart failure.
What could go wrong: This is a platform trial that hasn't started recruiting yet. Results depend on which interventions are tested, and many may not prove effective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE

More trials for these conditions

Other studies related to the condition(s) this trial covers.